Etiologies for seizures around the time of vaccination

Pediatrics

Volumn 134, Issue 4, 2014, Pages 658-666

  Verbeek, Nienke E ^a   Jansen, Floor E ^b   De Bondt, Patricia E Vermeer ^c   De Kovel, Carolien G ^a   Van Kempen, Marjan J A ^a   Lindhout, Dick ^a   Knoers, Nine V A M ^a   Van Der Maas, Nicoline A T ^c   Brilstra, Eva H ^a  

^a Department of Medical Genetics ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Dravet syndrome; Epilepsy; Etiology; PCDH19; SCN1A; Seizure; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; BRAIN DISEASE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG SAFETY; EPILEPTIC ENCEPHALOPATHY; FEBRILE CONVULSION; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PARENTAL CONSENT; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEVERE MYOCLONIC EPILEPSY IN INFANCY; VACCINATION; ADVERSE EFFECTS; GENETICS; IMMUNIZATION; INFANT; NETHERLANDS; PEDIGREE; SEIZURES; TIME;

COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; NETHERLANDS; PEDIGREE; SEIZURES; TIME FACTORS; VACCINATION;

EID: 84924630666     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0690     Document Type: Article

References (39)

1. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: The untold story. Lancet. 1998;351(9099):356-361.
2. Barlow WE, Davis RL, Glasser JW, et al; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656-661.
3. Moore DL, Le Saux N, Scheifele D, Halperin SA; Members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program Active (IMPACT). Lack of evidence of encephalopathy related to pertussis vaccine: Active surveillance by IMPACT, Canada, 1993- 2002. Pediatr Infect Dis J. 2004;23(6):568-571.
4. Ray P, Hayward J, Michelson D, et al; Vaccine Safety Datalink Group. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J. 2006;25(9):768- 773.
5. Ward KN, Bryant NJ, Andrews NJ, et al. Risk of serious neurologic disease after immunization of young children in Britain and Ireland. Pediatrics. 2007;120(2):314-321.
6. Sun Y, Christensen J, Hviid A, et al. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012;307(8):823- 831.
7. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics. 1991;88(5):881-885.
8. Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: Evaluation of susceptible subgroups and longterm prognosis. JAMA. 2004;292(3):351-357.
9. Strebel PM, Papania MJ, Parker Fiebelkorn A, Halsey NA. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia, PA: Elsevier; 2012:352-387.
10. Berkovic SF, Harkin L, McMahon JM, et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study. Lancet Neurol. 2006;5(6):488-492.
11. Dravet C. The core Dravet syndrome phenotype. Epilepsia. 2011;52(suppl2):3-9.
12. Depienne C, Trouillard O, Saint-Martin C, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: Analysis of 33 patients. J Med Genet. 2009;46(3):183-191.
13. Depienne C, Trouillard O, Gourfinkel-An I, et al. Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet. 2010;47(6): 404-410.
14. Mulley JC, Scheffer IE, Petrou S, Dibbens LM, Berkovic SF, Harkin LA. SCN1A mutations and epilepsy. Hum Mutat. 2005;25(6): 535-542.
15. McIntosh AM, McMahon J, Dibbens LM, et al. Effects of vaccination on onset and outcome of Dravet syndrome: A retrospective study. Lancet Neurol. 2010;9(6):592-598.
16. Reyes IS, Hsieh DT, Laux LC, Wilfong AA. Alleged cases of vaccine encephalopathy rediagnosed years later as Dravet syndrome. Pediatrics. 2011;128(3). Available at: Www.pediatrics.org/cgi/content/full/128/3/e699.
17. Verbeek NE, van der Maas NA, Jansen FE, van Kempen MJ, Lindhout D, Brilstra EH. Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: A population- based ten-year cohort study. PLoS One. 2013;8(6):e65758.
18. von Spiczak S, Helbig I, Drechsel-Baeuerle U, et al. A retrospective population-based study on seizures related to childhood vaccination. Epilepsia. 2011;52(8):1506-1512.
19. Jamal SM, Basran RK, Newton S, Wang Z, Milunsky JM. Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome. Am J Med Genet A. 2010;152A (10):2475-2481.
20. Novy J, Catarino CB, Chinthapalli K, et al. Another cause of vaccine encephalopathy: A case of Angelman syndrome. Eur J Med Genet. 2012;55(5):338-341.
21. Vermeer-de Bondt PE, Moorer-Lanser N, Phaff TA, Oostvogels B, Wesselo C, van der Maas NA. Adverse events in the Netherlands vaccination programme: Reports in 2010 and review 1994-2010. RIVM, Bilthoven 2011;205051004. Available at: http://www.rivm.nl/en/Documents-And-publications/.
22. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345(8949):567-569.
23. Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, Xie F, Cheetham TC, Saddier P. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine. 2009;27(34):4656-4661.
24. van der Maas NA, Phaff TAJ, Wesselo C, Vermeer-de Bondt PE. Adverse events following immunizations under the national vaccination programme of the Netherlands. Number XIII-reports in 2006. RIVM, Bilthoven 2007;240071004. Available at: http://www.rivm.nl/en/Documents-And-publications/.
25. Vermeer-de Bondt PE, Moorer-Lancer N, Phaff TAJ, Oostvogels B, Wesselo C, Maas van der NAT. Adverse events in the Netherlands Vaccination Programme; reports in 2010 and review 1994-2010. RIVM, Bilthoven 2011, 205051004. Available at: http://www.rivm.nl/en/Documents-And-publications/.
26. David S, Vermeer-de Bondt PE, van der Maas NA. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. Vaccine. 2008;26(46):5883-5887.
27. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-685.
28. van Harssel JJ, Weckhuysen S, van Kempen MJ, et al. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders. Neurogenetics. 2013;14(1):23-34.
29. Volkers L, Kahlig KM, Verbeek NE, et al. Nav 1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome. Eur J Neurosci. 2011;34(8):1268-1275.
30. Caraballo RH, Fejerman N. Dravet syndrome: A study of 53 patients. Epilepsy Res. 2006;70(suppl1):S231-S238.
31. Nieto-Barrera M, Lillo MM, Rodríguez-Collado C, Candau R, Correa A. Severe myoclonic epilepsy in childhood. Epidemiologic analytical study [in Spanish]. Rev Neurol. 2000;30 (7):620-624.
32. Tro-Baumann B, von Spiczak S, Lotte J, et al. A retrospective study of the relation between vaccination and occurrence of seizures in dravet syndrome. Epilepsia. 2011; 52(1):175-178.
33. Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 2009;5(2):e1000381.
34. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120(pt 3):479-490.
35. van Bon BW, Koolen DA, Borgatti R, et al. Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet. 2008; 45(6):346-354.
36. Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001; 68(4):859-865.
37. Zamponi N, Passamonti C, Petrelli C, et al. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: A multicenter Italian study. Pediatr Neurol. 2014;50 (3):228-232.
38. Hasford J, Goettler M, Munter KH, Müller- Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55(9):945-950.
39. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995;85(12):1706-1709.